Submitted by Anonymous (not verified) on 27 January 2026 - 16:25
Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Date of authorisation: 01/10/2008, Revision: 19, Status: Authorised
Source: